The Board of JSC Grindeks announces that the mandatory share repurchase offer will not affect its view in paying dividends, and the overall development of the Grindeks Group currently indicates its ability to sustain consistent dividend levels in the future.
The decision on profit distribution of the previous year is taken exclusively by Grindeks’ Shareholders’ meeting.
Bringing forward the draft decision on the Group profit distribution for the previous year, the Board takes into consideration the following factors:
- Dynamic development of product portfolio and competitiveness in the generic medicines’ market;
- Implementation of the business development strategy in European Union and Southeast Asia countries and improving of the commercial policy in traditional markets – Russia and other CIS countries.